Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua

Pediatric Infectious Disease Journal

Volumn 33, Issue 6, 2014, Pages 637-642

  Becker Dreps, Sylvia ^a   Amaya, Erick ^b   Liu, Lan ^c   Moreno, Gilberto ^d   Rocha, Julio ^e   Briceño, Rafaela ^d   Alemán, Jorge ^f   Hudgens, Michael G ^c   Woods, Christopher W ^g   Weber, David J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b National Autonomous University of Nicaragua   (Nicaragua)

^c IL   (United States)

^d Sistemas Locales de Atención Integral A la Salud León SILAIS León   (Nicaragua)

^e Hospital Epidemiology   (South Africa)

^f Hospital Escuela Dr Oscar Danilo Rosales Arguello (HEODRA)   (Nicaragua)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

13 valent pneumococcal vaccine; childhood; Nicaragua; Pneumonia; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; PREVENAR13; VACCINE;

AMBULATORY CARE; ARTICLE; CHILD; CHILDHOOD; DIARRHEA; GROUPS BY AGE; HEALTH CARE FACILITY; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; INFANT MORTALITY; NICARAGUA; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; ADOLESCENT; CHILDHOOD MORTALITY; INFANT; MORTALITY; PNEUMONIA, PNEUMOCOCCAL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFANT MORTALITY; NICARAGUA; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; VACCINES, CONJUGATE;

EID: 84901479552     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000269     Document Type: Article

References (24)

1. O'Brien KL Wolfson LJ Watt JP et al.; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902.
2. Grijalva CG Nuorti JP Arbogast PG et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369:1179-1186 . (Pubitemid 46527876)
3. Jardine A Menzies RI McIntyre PB. Reduction in hospitalizations for pneumonia associated with the introduction of a pneumococcal conjugate vaccination schedule without a booster dose in Australia. Pediatr Infe ct Dis J. 2010;29:607-612.
4. Koshy E Murray J Bottle A et al. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumon ia and empyema in England: national time-trends study 1997-2008. Thorax. 2010;65:770-774.
5. Pírez MC Algorta G Cedrés A et al. Impact of universal pneumococcal vaccination on hospitaliz ations for pneumonia and meningitis in children in Montevideo Uruguay. Pediatr Infect Dis J. 2011;30:669-674.
6. Ho PL Chiu SS Chow FK et al. Pediatric hospitalization for pneumococcal diseases p reventable by 7-valent pneumococcal conjugate vaccine in Hong Kong. Vaccine. 2007;25:6837-6841. (Pubitemid 47391110)
7. World Health Organization (WHO). Weekly epidemiological record: Pneumococcal vaccines WHO position paper-2012. Available at: http://www.who.int/werhttp://www.who.int/wer/2012/wer8714.pdf. Accessed September 5 2013.
8. The World Bank. GDP per capita. 2013. Available at: http://data. worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed September 5 2013.
9. Nicaraguan Ministry of Health. We ekly epidemiological bulletin. July 3 2013. Available at: http://www.minsa.gob.ni/index.phpoption=com-remos itory&Itemid=52&func=startdown&id=9102. Accessed September 5 2013.
10. Pan American Health Organization (PAHO SIREVA II. Informes y publicaciones técnicas. Available at http://www.paho.org/hq/index. phpoption=com-content&view=category&layout=blog&id=3609&Ite mid=3953 2012. Accessed December 2 2013.
11. Nicaraguan Ministry of Health. Guide for the management of the most common infectious diseases in childhood and malnutrition. March 11 2011. Available at: http://www.minsa.gob.ni/index.php/ repository/Descargas-MINSA/ Dirección-General-de-Regulación-Sanitaria/Normas-Protocolosy- Manuales/Normas-2009/normativa-017-Guía-para-el-Abordaje-de-las- Enfermedades-Infecciosas-m ás-Comunes-de-la-Infancia-y-la- Destrución/Accessed December 4 2013.
12. Griffin MR Zhu Y Moore MR et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369: 155-163.
13. Zhou F K yaw MH Shefer A et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med. 2007;161:1162-1168. (Pubitemid 350223571)
14. Kronman MP Hersh AL Feng R et al. Ambulatory visit rates and antibiotic prescribing for children with pneumonia 1994-2007. Pediatrics. 2011;127:411-418.
15. Grijalva CG Poeh ling KA Nuorti JP et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873. (Pubitemid 46090026)
16. Paynter S Ware RS Lucero MG et al.; ARIVAC Consortium. Poor growth and pneumonia seasonality in infants in the Philippines: cohort and time series studies. PLoS One. 2013;8:e67528.
17. Enwe re G Cheung YB Zaman SM et al. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Trop Med Int Health. 2007;12:1377-1385. (Pubitemid 350191133)
18. Shek LP Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr Respir Rev. 2003;4:105-111.
19. Weber MW Mulholland EK Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health. 1998;3:268-280. (Pubitemid 28232663)
20. Akinsola AK Ota MO Enwere GC et al. Pneumococcal antibody concentrations and carriage of pneumococ ci more than 3 years after infant immunization with a pneumococcal conjugate vaccine. PLoS One. 2012;7:e31050.
21. Jardine A Menzies RI McIntyre PB. Reduction in hospitalizations for pneumonia associated with the introduction of a pneumococcal conjugate vaccination schedule without a booster dose in Australia. Pediatr Infect Dis J. 2010;29:607-612.
22. Advisory Committee on Immunization Practices. Considerations for a 3-dose PCV-13 schedule for infants. October 24 2013. Available at: http://www.cdc.gov/vaccines/acip/meetings/downl oads//slides-oct-2013/03- Pneumococcal-Pilishvili.pdf. Accessed February 15 2014.
23. Centers for Disease Control and Prevention. Immunization Coverage in the U.S. 2002 Tables. July 15 2003. Available at: http://www.cdc.gov/vaccines/stats- surv/nis/data/tables-2002.htm
24. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011;52 (suppl 4):S296-S304.